
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
"Why Should I Trust You?" A Podcast Partnership to Rebuild Public Trust in Science
In an age where misinformation spreads faster than facts, the public’s trust in science is at an...
Free Access: Insights from Long COVID & Other Post-Acute Infection Syndromes Conference
Long COVID afflicts an estimated 11 million people in the United States alone (5% of the...
Insights from Sold-Out Interoception Conference: Scientific Breakthroughs, Community Highlights & Nobel Laureate Dr. David Julius
The brain-body connection was on full display at the April Keystone Symposia on interoception at...
Keypoint Newsletter: May 2025
Upcoming Fall 2025 Conference Highlights & Organizer Interviews
Our Fall 2025 line-up features exciting topics across infectious disease, artificial intelligence...
Colorado State Capitol Tribute to Keystone Symposia
On Monday March 3, Keystone Symposia was recognized by the Colorado State Senate and House of...
April Fellow's Spotlight on Dr. Vivien Maltez
Our April Fellow's Spotlight goes to Dr. Vivien Maltez, PhD, an Assistant Professor in the Division...
Partnering with Eli Lilly to Empower the Biomedical Workforce
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to...
Keystone Symposia Aims to Increase Global Impact-- Experts Weigh in on Strategy
By Gillian Dorn & Shannon Weiman